共 12 条
[3]
Molecular Epidemiology of Clostridium difficile Infection in a Major Chinese Hospital: an Underrecognized Problem in Asia?[J] . Peter M. Hawkey,Clare Marriott,Wen En Liu,Zi Juan Jian,Qian Gao,Thomas Kin Wah Ling,Viola Chow,Erica So,Raphael Chan,Katie Hardy,Li Xu,Susan Manzoor.Journal of Clinical Microbiology . 2013 (10)
[4]
Rifaximin in the treatment of recurrent Clostridium difficile infection[J] . E. Mattila,P. Arkkila,P. S. Mattila,E. Tarkka,P. Tissari,V.‐J. Anttila.Aliment Pharmacol Ther . 2012 (1)
[5]
Burden of Clostridium difficile on the Healthcare System[J] . Erik R. Dubberke,Margaret A. Olsen.Clinical Infectious Diseases . 2012 (supp)
[6]
Clostridium difficile infection in Europe: a hospital-based survey[J] . Martijn P Bauer,Daan W Notermans,Birgit HB van Benthem,Jon S Brazier,Mark H Wilcox,Maja Rupnik,Dominique L Monnet,Jaap T van Dissel,Ed J Kuijper.The Lancet . 2011 (9759)
[7]
Biology of Clostridium difficile: Implications for Epidemiology and Diagnosis[J] . Carroll Karen C.,Bartlett John G..Annual Review of Microbiology . 2011
[8]
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)[J] . M.P. Bauer,E.J. Kuijper,J.T. van Dissel.Clinical Microbiology and Infection . 2009 (12)
[10]
Epidemiology, Pathogenesis, and Management of Clostridium difficile Infection[J] . Rajaraman Durai.Digestive Diseases and Sciences . 2007 (11)